Description
Vabysmo (faricimab) is a prescription injectable solution manufactured by Genentech, Inc., administered via intravitreal injection (into the eye) for treating certain retinal conditions. It contains faricimab at 6 mg per 0.05 mL dose. This information was generated using AI and is provided for informational and research purposes only.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Faricimab | HTML | Access the FDA dataset for Faricimab — ANDA 761235 submitted by Mylan Institutional LLC | Open resource |